ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
The ferroptosis-ncRNA-exosome triad: key orchestrators in cancer immunopathogenesis.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oxidative Stress andInternational journal of molecular sciences · 2026Review
- From gut-reproductive microbiota to ferroptosis: a comprehensive insight into the molecular-pathogenicity of endometriosis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ferroptosis is an iron-dependent lipid peroxidation-regulated cell death mechanism that serves a paradoxical role in cancer immunopathogenesis. The complex relationships between ferroptosis, exosomes, and non-coding RNAs (ncRNAs) have recently been identified as an attractive subject in the field of immune system regulation in cancer. Although ferroptosis activates immune responses by inducing the release of damage-associated molecular patterns (DAMPs), it can also result in immune tolerance via the release of immunosuppressive molecules, highlighting the dual role of ferroptosis in either immune activation or suppression. Exosomes function as key components of the tumor microenvironment for regulating ferroptosis and immune responses, in which they protect cancer cells from ferroptosis and contribute to immunosuppression and metabolic remodeling. lncRNAs regulate ferroptosis through modulating miRNAs; for instance, lncRNA PVT1 or exosomal-PVT1 has been shown to cause miR-214-3p-mediated GPX4 inhibition, inducing ferroptosis in hepatocellular cancer cells in vitro. In this regard, elucidating the precise correlation between ferroptosis, exosome dynamics, and lncRNA involved in cancer immunopathogenesis may reveal new therapeutic approaches to improve cancer treatment success. Combining ferroptosis regulation with immunotherapy shows promise for cancer treatment; however, additional studies are required to understand these mechanisms for developing innovative therapeutic approaches for cancer patients.
Indexed as
Identifiers
40960518What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.